Dipeptidyl peptidase 4 inhibitor attenuates obesity-induced myocardial fibrosis by inhibiting transforming growth factor-βl and Smad2/3 pathways in high-fat diet-induced obesity rat model

Metabolism ◽  
2017 ◽  
Vol 76 ◽  
pp. 42-55 ◽  
Author(s):  
Seul-Ki Hong ◽  
Eun-Ho Choo ◽  
Sang-Hyun Ihm ◽  
Kiyuk Chang ◽  
Ki-Bae Seung
Keyword(s):  
Growth Factor ◽  
Myocardial Fibrosis ◽  
Rat Model ◽  
High Fat Diet ◽  
Transforming Growth Factor ◽  
Dipeptidyl Peptidase ◽  
High Fat ◽  
Dipeptidyl Peptidase 4 ◽  
Diet Induced Obesity ◽  
Dipeptidyl Peptidase 4 Inhibitor

Mo1913 Influence of a Dipeptidyl Peptidase-4 Inhibitor on Intestinal Neoplasia Formation in APC MIN/+ Mice Fed a High Fat Diet

2014 ◽  
Vol 146 (5) ◽  
pp. S-690
Author(s):  
Kaori Fujiwara ◽  
Takuya Inoue ◽  
Naoki Yorifuji ◽  
Munetaka Iguchi ◽  
Taisuke Sakanaka ◽  
...  
Keyword(s):  
High Fat Diet ◽  
Dipeptidyl Peptidase ◽  
High Fat ◽  
Dipeptidyl Peptidase 4 ◽  
Intestinal Neoplasia ◽  
Dipeptidyl Peptidase 4 Inhibitor

Dipeptidyl peptidase-4 inhibitor anagliptin ameliorates diabetes in mice with haploinsufficiency of glucokinase on a high-fat diet

Metabolism ◽  
2013 ◽  
Vol 62 (7) ◽  
pp. 939-951 ◽  
Author(s):  
Keizo Nakaya ◽  
Naoto Kubota ◽  
Iseki Takamoto ◽  
Tetsuya Kubota ◽  
Hisayuki Katsuyama ◽  
...  
Keyword(s):  
High Fat Diet ◽  
Dipeptidyl Peptidase ◽  
High Fat ◽  
Dipeptidyl Peptidase 4 ◽  
Diabetes In Mice ◽  
Dipeptidyl Peptidase 4 Inhibitor
Sign in / Sign up

Export Citation Format

Share Document